Financial reports
10-Q
2024 Q1
Quarterly report
25 Apr 24
ARS
2023 FY
Annual report to shareholders
22 Apr 24
10-K
2023 FY
Annual report
8 Feb 24
10-Q
2023 Q3
Quarterly report
26 Oct 23
10-Q
2023 Q2
Quarterly report
27 Jul 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
10-K
2022 FY
Annual report
9 Feb 23
10-Q
2022 Q3
Quarterly report
27 Oct 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
Current reports
8-K
Dexcom Reports First Quarter 2024 Financial Results
25 Apr 24
8-K
Entry into a Material Definitive Agreement
15 Feb 24
8-K
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
8 Feb 24
8-K
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
8 Jan 24
8-K
Other Events
2 Nov 23
8-K
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program
26 Oct 23
8-K
Other Events
26 Oct 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Dexcom Reports Second Quarter 2023 Financial Results
27 Jul 23
8-K
Dexcom Updates Long-Range Financial Targets
23 Jun 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
22 Nov 21
S-3ASR
Automatic shelf registration
22 Nov 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
Proxies
DEF 14A
Definitive proxy
22 Apr 24
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
DEFA14A
Additional proxy soliciting materials
8 Apr 22
DEF 14A
Definitive proxy
8 Apr 22
PRE 14A
Preliminary proxy
25 Mar 22
DEFA14A
Additional proxy soliciting materials
9 Apr 21
DEF 14A
Definitive proxy
9 Apr 21
PRE 14A
Preliminary proxy
26 Mar 21
DEFA14A
Additional proxy soliciting materials
8 May 20
Other
SD
Conflict minerals disclosure
31 May 23
SD
Conflict minerals disclosure
31 May 22
UPLOAD
Letter from SEC
5 May 22
CORRESP
Correspondence with SEC
3 May 22
UPLOAD
Letter from SEC
21 Apr 22
CORRESP
Correspondence with SEC
29 Mar 22
UPLOAD
Letter from SEC
22 Mar 22
SD
Conflict minerals disclosure
1 Jun 21
SD
Conflict minerals disclosure
1 Jun 20
SD
Conflict minerals disclosure
30 May 19
Ownership
144
Notice of proposed sale of securities
23 Apr 24
4
Matthew Vincent Dolan
16 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
KEVIN R SAYER
10 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Michael Jon Brown
29 Mar 24
144
Notice of proposed sale of securities
28 Mar 24
4
Sadie Stern
26 Mar 24
144
Notice of proposed sale of securities
25 Mar 24